UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 211

Sortiert nach

Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB

Antimicrobial agents and chemotherapy, 2016-07, Vol.60 (7), p.4315-4323

2016

Link zum Volltext

Verfügbarkeit prüfen

Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates

International journal of molecular sciences, 2022-05, Vol.23 (9), p.5071

2022

Link zum Volltext

Verfügbarkeit prüfen

RFS Proudly Announces the 2022 Award Recipient for Microbial Drug Resistance

Microbial drug resistance (Larchmont, N.Y.), 2023-07, Vol.29 (7), p.273

Schuster, Sabine

2023

Link zum Volltext

Verfügbarkeit prüfen

Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice

International journal of molecular sciences, 2019-09, Vol.20 (19), p.4763

2019

Link zum Volltext

Verfügbarkeit prüfen

Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli

Journal of antimicrobial chemotherapy, 2011-09, Vol.66 (9), p.2057-2060

2011

Link zum Volltext

Verfügbarkeit prüfen

Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis

Molecules (Basel, Switzerland), 2019-01, Vol.24 (3), p.470

2019

Link zum Volltext

Verfügbarkeit prüfen

Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1864

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds

Microbiology spectrum, 2024-02, Vol.12 (2), p.e0304523-e0304523

2024

Link zum Volltext

Verfügbarkeit prüfen

A continuous sirtuin activity assay without any coupling to enzymatic or chemical reactions

Scientific reports, 2016-03, Vol.6 (1), p.22643-22643, Article 22643

2016

Link zum Volltext

Verfügbarkeit prüfen

Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors

Antimicrobial agents and chemotherapy, 2014-11, Vol.58 (11), p.6870-6878

2014

Link zum Volltext

Verfügbarkeit prüfen

Exploring the Contribution of the AcrB Homolog MdtF to Drug Resistance and Dye Efflux in a Multidrug Resistant E. coli Isolate

Antibiotics (Basel), 2021-04, Vol.10 (5), p.503

2021

Link zum Volltext

Verfügbarkeit prüfen

Site-Directed Mutagenesis Reveals Putative Substrate Binding Residues in the Escherichia coli RND Efflux Pump AcrB

Journal of Bacteriology, 2008-12, Vol.190 (24), p.8225-8229

2008

Link zum Volltext

Verfügbarkeit prüfen

Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli

Journal of antimicrobial chemotherapy, 2006-02, Vol.57 (2), p.339-343

2006

Link zum Volltext

Verfügbarkeit prüfen

Determination of real-time efflux phenotypes in Escherichia coli AcrB binding pocket phenylalanine mutants using a 1,2'-dinaphthylamine efflux assay

PloS one, 2011-06, Vol.6 (6), p.e21196-e21196

2011

Link zum Volltext

Verfügbarkeit prüfen

Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification

Pharmaceutics, 2018-11, Vol.10 (4), p.223

2018

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin-GnRH-III conjugates developed for targeted drug delivery

Beilstein journal of organic chemistry, 2018, Vol.14 (1), p.756-771

2018

Link zum Volltext

Verfügbarkeit prüfen

Leben mit der honigsüßen Krankheit: Diabetes mellitus und Schule

Schuster, Sabine

2014

Link zum Volltext

Verfügbarkeit prüfen

Efflux-Mediated Resistance to New Oxazolidinones and Pleuromutilin Derivatives in Escherichia coli with Class Specificities in the Resistance-Nodulation-Cell Division-Type Drug Transport Pathways

Antimicrobial agents and chemotherapy, 2019-09, Vol.63 (9)

2019

Link zum Volltext

Verfügbarkeit prüfen

A Screening of Antimalarials Extends the Range of Known Escherichia coli AcrB Efflux Substrates and Reveals Two Candidates with Antimicrobial Drug-Enhancing Activity

Microbial drug resistance (Larchmont, N.Y.), 2022-12, Vol.28 (12), p.1065

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial

Wiener Klinische Wochenschrift, 2021-09, Vol.133 (17-18), p.931-941

2021

Link zum Volltext

Verfügbarkeit prüfen

Coupled Production of Steel and Chemicals

Chemie ingenieur technik, 2018-11, Vol.90 (11), p.1782-1805

2018

Link zum Volltext

Verfügbarkeit prüfen

Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131

Antimicrobial agents and chemotherapy, 2021-03, Vol.65 (4)

2021

Link zum Volltext

Verfügbarkeit prüfen

New Topoisomerase Inhibitors: Evaluating the Potency of Gepotidacin and Zoliflodacin in Fluoroquinolone-Resistant Escherichia coli upon tolC Inactivation and Differentiating Their Efflux Pump Substrate Nature

Antimicrobial agents and chemotherapy, 2021-01, Vol.65 (2)

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.1974-1983

2016

Link zum Volltext

Verfügbarkeit prüfen

The Role of Pd2+/Pd0 in Hydrogenation by [Pd(2-pymo)2]n: An X-ray Absorption and IR Spectroscopic Study

Chemistry : a European journal, 2012-12, Vol.18 (49), p.15831-15837

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(185)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(170)
Deutsch
(41)
Japanisch
(27)
Ungarisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(91)
Humans
(61)
Female
(24)
Biological And Medical Sciences
(21)
Male
(21)
Microbiology
(21)
Animals
(19)
Pharmacology & Pharmacy
(19)
Physical Sciences
(18)
Biochemistry & Molecular Biology
(15)
Chemistry
(15)
Medical Sciences
(15)
Adult
(13)
Escherichia Coli
(13)
Medicine
(13)
Microbial Sensitivity Tests
(13)
Mutation
(13)
Science & Technology - Other Topics
(13)
Anti-Bacterial Agents - Pharmacology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB

Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates

RFS Proudly Announces the 2022 Award Recipient for Microbial Drug Resistance

Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice

Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli

Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis

Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview

Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds

A continuous sirtuin activity assay without any coupling to enzymatic or chemical reactions

Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors

Exploring the Contribution of the AcrB Homolog MdtF to Drug Resistance and Dye Efflux in a Multidrug Resistant E. coli Isolate

Site-Directed Mutagenesis Reveals Putative Substrate Binding Residues in the Escherichia coli RND Efflux Pump AcrB

Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli

Determination of real-time efflux phenotypes in Escherichia coli AcrB binding pocket phenylalanine mutants using a 1,2'-dinaphthylamine efflux assay

Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification

Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin-GnRH-III conjugates developed for targeted drug delivery

Leben mit der honigsüßen Krankheit: Diabetes mellitus und Schule

Efflux-Mediated Resistance to New Oxazolidinones and Pleuromutilin Derivatives in Escherichia coli with Class Specificities in the Resistance-Nodulation-Cell Division-Type Drug Transport Pathways

A Screening of Antimalarials Extends the Range of Known Escherichia coli AcrB Efflux Substrates and Reveals Two Candidates with Antimicrobial Drug-Enhancing Activity

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial

Coupled Production of Steel and Chemicals

Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131

New Topoisomerase Inhibitors: Evaluating the Potency of Gepotidacin and Zoliflodacin in Fluoroquinolone-Resistant Escherichia coli upon tolC Inactivation and Differentiating Their Efflux Pump Substrate Nature

Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay

The Role of Pd2+/Pd0 in Hydrogenation by [Pd(2-pymo)2]n: An X-ray Absorption and IR Spectroscopic Study

Suchergebnisse filtern